Organisation paid for research Program year 2022 Source: CMS Open Payments

Multi-Specialty Research

Neither a doctor nor a teaching hospital

Research payments

$653,684

40 payments

Through program year 2022, Multi-Specialty Research is reported as receiving $653,684 in research payments, across 40 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$99,530	9
2021	Research	$496,498	29
2020	Research	$57,656	2

Breakdown

Who paid Research payments · program years 2020–2022

Biohaven Pharmaceuticals, Inc. $554,154 31 payments
Biohaven Pharmaceutical Holding Company Ltd. $99,530 9 payments

Studies the money was for Research payments · program years 2020–2022

A Phase 2/3 Open-label Long-Term Safety Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $318,530 18 payments
BHV3500-301: Phase 3: Double-Blind Randomized Placebo Controlled Safety and Efficacy Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $277,498 20 payments
A Phase 2/3 Open-label, Long-Term, Safety Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $36,051 1 payment
BHV3500-301: Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $21,606 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.